Health
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 – Science Magazine
Many efforts to develop therapies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are focused on the interaction between the spike protein,…
Abstract
We developed a de novo protein design strategy to swiftly engineer decoys for neutralizing pathogens that exploit extracellular host proteins to infect the cell. Our pipeline allowed the design, validation, and optimization of de novo human angiotensin-converting enzyme 2 (hACE2) decoys to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The best monovalent decoy, CTC-445.2, bound with low nanomolar affinity and high specificity to the receptor-binding domain (RBD)…
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
General22 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News22 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland